Related Experiment Video
Updated: May 4, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA
Published on: February 9, 2011
[Invasive streptococcal (group A) infection of soft tissues in a Moscow surgical hospital]
Aim:
To study features and risk factors of soft tissue's invasive streptococcal infection in surgical unit's patients: a) emm-types of the most often recovered streptococcus; b) human immune response for streptococcal antigens (streptolysin-O and the group A carbohydrate antigen); c) main patient's conditions that complicate the course of soft tissue's streptococcal infection.
Patients And Methods:
101 surgical unit's patients with soft tissue's infection, which group A streptococcal (GAS) nature, were examined. Emm-types were determined by comparison ofemm gene sequenced part with data of CDC Streptococcus Laboratory. ASO and specific anti-group-carbohydrate IgM were measured with photometry and ELISA4 accordingly. Patient's personal data were analyzed by standard statistical programs.
Results:
Among 34 emm-types of all streptococcal isolates emm28 and emm64 were registered only in invasive infection. Emm-types 1, 49, 60, 66, 77, 84, 88 were most often. Among 23 sera from invasive GAS-infection's patients, 15(65%) were ASO-negative, 6 (26%) were ASO-low-positive, and 2 (8%) were positive, but negative for the anti-group-A-carbohydrate IgM.
Conclusion:
Lower levels of the humoral immune response as well as risk factors such as trauma, alcoholism, diabetes, chronic venous insufficiency contributed to development of severe forms of GAS-infection. The main streptococcal emm-types for soft tissue's invasive GAS infection in one of Moscow surgical unit's patients in 2008-2011 were registered.
Insights
Invasive streptococcal soft tissue infections were linked to specific emm-types and lower immune responses. Risk factors like trauma and diabetes worsened outcomes in surgical patients.
Area of Science:
- Infectious Diseases
- Immunology
- Microbiology
Background:
- Soft tissue infections caused by Group A Streptococcus (GAS) can lead to severe invasive disease.
- Understanding the specific bacterial strains and host immune responses is crucial for managing these infections.
- Identifying patient risk factors can aid in early detection and prevention of severe GAS infections.
Purpose of the Study:
- To characterize the emm-types of Streptococcus prevalent in invasive soft tissue infections.
- To assess the human immune response to streptococcal antigens, specifically streptolysin-O and group A carbohydrate.
- To identify patient conditions that increase the risk and severity of invasive streptococcal soft tissue infections.
Main Methods:
- A cohort of 101 surgical patients with confirmed GAS soft tissue infections was studied.
- emm-typing was performed by sequencing the emm gene and comparing it to the CDC database.
- Anti-streptolysin-O (ASO) and anti-group A carbohydrate IgM levels were measured using photometry and ELISA.
Main Results:
- emm28 and emm64 were exclusively found in invasive infections among 34 identified emm-types.
- The most frequent emm-types identified were 1, 49, 60, 66, 77, 84, and 88.
- Invasive GAS infection patients showed a high prevalence of negative (65%) or low-positive (26%) ASO titers.
Conclusions:
- Reduced humoral immune response, alongside risk factors like trauma, alcoholism, diabetes, and chronic venous insufficiency, contributes to severe GAS infections.
- Specific emm-types were identified as predominant in invasive soft tissue GAS infections in the studied surgical unit population.
- These findings highlight the importance of immune status and pre-existing conditions in the pathogenesis of invasive streptococcal infections.
Related Concept Videos
Staphylococcal Skin Infections
Bacterial Meningitis I: Introduction
Brain Abscess l: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Endocarditis I: Introduction

